Profiel
Jing Zhen Deng served as the Chief Executive Officer of Jiangsu Suxantang Pharmaceutical Co. Ltd.
from 2018 to 2019.
Prior to that, he was the Chief Executive Officer of RCT Pharmaceuticals, Inc. and Director of Research & Development at Pinnacle Pharmaceuticals, Inc. and Drumetix Laboratories.
Deng also served as the Chief Operation & Scientific Officer of China Sxt Pharmaceuticals, Inc. from 2017 to 2021.
Deng received his undergraduate degree from Jiangxi University of Traditional Chinese Medicine in 1982 and his graduate and doctorate degrees from China Pharmaceutical University in 1989 and 1992, respectively.
Eerdere bekende functies van Jing Zhen Deng
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINA SXT PHARMACEUTICALS, INC. | Operationeel Directeur | 15-12-2021 |
| Jiangsu Suxantang Pharmaceutical Co. Ltd. | Algemeen Directeur | 31-12-2019 |
| RCT Pharmaceuticals, Inc. | Algemeen Directeur | - |
| Drumetix Laboratories | Hoofd Techniek/Wetenschap/O&O | - |
| Pinnacle Pharmaceuticals, Inc. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jing Zhen Deng
| Jiangxi University of Traditional Chinese Medicine | Undergraduate Degree |
| China Pharmaceutical University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHINA SXT PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Jiangsu Suxantang Pharmaceutical Co. Ltd. | |
| Pinnacle Pharmaceuticals, Inc. | |
| Drumetix Laboratories | |
| RCT Pharmaceuticals, Inc. |
